Emergency hemicolectomy for intestinal primary aspergillosis in acute myeloid leukemia

M Imola1, A M Mianulli, G Pasini

  • 1Department of Oncology (Instituto Ondologico Romagnolo), General Surgery, Infermi Hospital, Rimini, Italy.

Insights

This case study details a successful treatment for intestinal aspergillosis, a rare and dangerous infection, in a patient with acute myeloid leukemia. Aggressive surgical intervention and antifungal therapy led to a full recovery.

Area of Science:

  • Medical Mycology
  • Hematology
  • Gastroenterology

Background:

  • Intestinal aspergillosis is a life-threatening infection, particularly in immunocompromised patients such as those with acute myeloid leukemia (AML).
  • Early diagnosis and prompt management are critical for improving patient outcomes.

Observation:

  • A 46-year-old female diagnosed with acute myeloid leukemia (LAM M5) developed primary intestinal aspergillosis following induction chemotherapy.
  • The patient presented with neutropenia, persistent fever, severe diarrhea, and abdominal distention, initially without clear infective foci.
  • Diagnostic imaging failed to reveal focal lesions, complicating the initial assessment and treatment.

Findings:

  • Histopathological examination confirmed necrotizing colitis with Aspergillus hyphae, establishing the diagnosis of intestinal aspergillosis.
  • A two-step surgical approach, including ileostomy and colectomy, combined with voriconazole treatment, led to rapid clinical improvement.
  • The patient achieved a complete recovery and was able to resume further anti-leukemic therapies.

Implications:

  • This case highlights the importance of considering invasive fungal infections in neutropenic patients with gastrointestinal symptoms, even without obvious focal findings.
  • Aggressive surgical management combined with appropriate antifungal therapy can be highly effective in treating intestinal aspergillosis in leukemia patients.
  • Successful treatment of intestinal aspergillosis can enable the continuation of essential anti-leukemic treatments, improving overall prognosis.

Related Concept Videos